Structurally, BioMarin Pharmaceutical and Workday are closely matched — neither holds a meaningful edge overall. Workday still leads on growth and stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.
The comparison is based on similar long-term financial trajectories, not sector labels.
The page question resolves more clearly through growth, even though the overall score is effectively tied.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.
The match is driven mainly by revenue growth trajectory and investment intensity.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
Workday, Inc. still looks cheaper, even though BioMarin Pharmaceutical Inc. remains structurally stronger.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The current lead is backed by a stronger multi-year growth trajectory.
Workday, Inc. still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.
Growth is the clearest driver of the lead, with profitability adding further support — though growth still provides a real counterweight.
Break down the BMRN vs WDAY comparison across all dimensions with the full interactive tool.
Explore how BMRN and WDAY each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.